Skip to search formSkip to main contentSkip to account menu

lonazolac

Known as: 3-(4-chlorophenyl)-1-phenylpyrazole-4-acetic acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Two new prodrugs of lonazolac, lonazolac acetic acid ester and lonazolac argininate, were prepared and examined for… 
1985
1985
The immunological effect of lonazolac on mononuclear cell activation has been investigated using the indirect Leukocyte Adherence… 
1984
1984
In 15 patients with inflammatory and degenerative joint disease the concentrations of lonazolac were measured in serum and… 
1982
1982
Two groups of patients, each consisting of 20 patients suffering from spinal osteoarthrosis, coxarthrosis or gonarthrosis… 
1982
1982
According to a Latin Square-2 block study design gastrointestinal blood loss after medication with lonacolac-Ca (200 mg t.i.d… 
1981
1981
Calcium-[3-(p-chlorophenyl)-1-phenylpyrazole-4]-acetate (Lonazolac-Ca, active principle of Irritren) is a new antiinflammatory… 
1981
1981
During a controlled open long-term study, Lonazolac-Ca, a new nonsteroidal antiphlogistic substance, has been tested in 35… 
1981
1981
In order to inhibit postoperative swelling we compared the new antiphlogistic Lonazolac-Ca with Diclofenac-Na in 20 patients each… 
1978
1978
  • J. Dethlefs
  • 1978
  • Corpus ID: 24238396
Using two experimental models of acute dermatitis in man, Lonazolac proved to possess dose-dependent anti-inflammatory effects…